Clinical Ink announced that it entered into a collaboration with Tandem Diabetes Care (Nasdaq:TNDM) to integrate automated insulin delivery (AID) data. The collaboration enables the integration of Tandem’s t:slim X2 and Mobi AID systems with Clinical Ink’s GlucoseReady platform. This would provide an automated method for capturing AID system data in clinical trials. In the partnership, […]
